Thursday

2nd Dec 2021

EU defends its slower vaccine authorisation

  • The procedure followed by the British authorities gives the companies complete immunity from legal liability in civil cases (Photo: Nathan Forget)

"The promise of vaccines is phenomenal [and] the reward is potentially game-changing," World Health Organization (WHO) regional director for Europe Hans Kluge said on Thursday (3 December), as the UK became the first Western country to approve a vaccine.

However, recent WHO studies indicate that about half of the population in some European countries are unsure about vaccination against Covid-19.

Read and decide

Join EUobserver today

Become an expert on Europe

Get instant access to all articles — and 20 years of archives. 14-day free trial.

... or subscribe as a group

For Kluge, "it's understandable to be concerned about vaccination in the current circumstances in which much is still unknown" - such as which vaccines will eventually be licensed, when they will be available and their potential side effects, if any.

The reassurance comes a day after the UK became the first Western country to approve a vaccine and the first in the world to give the green light to the vaccine jointly developed by US's firm Pfizer and Germany's BioNTech - with the UK's rollout expected to at least begin next week.

The UK's medicines regulatory agency announced the decision on Wednesday, just weeks after the companies released first data from the final stage of their clinical trial.

The procedure followed by the British authorities, however, gives the companies complete immunity from legal liability in civil cases.

The license, known as an "emergency use authorisation," has been traditionally used to allow medical products under emergency conditions which have not been already approved by the European Medicine Agency (EMA).

Under EU law, all member states can opt for this approach.

However, a commission official said on Thursday that for member states, it is important that the vaccine approval goes through the EU agency, since the trust of citizens is at stake.

Nevertheless, Hungary may end up using this opt-out approach for the roll out the Russian-made vaccine Sputnik V.

UK vs EMA

Meanwhile, the EMA is carrying out a fast-track but standardised regulatory process for the approval of two vaccines candidates, developed by Pfizer/BioNTech and Moderna, which have applied for EU-wide authorisation.

Under this approach, the same standards of quality, safety and efficacy for the approval of all EU medicines will apply to Covid-19 vaccines.

The Amsterdam-based agency, which moved from London after Brexit and is responsible for the scientific assessment of the data of all clinical trials, said this is the "most appropriate" method to approve the vaccine.

Data has been examined as it becomes available in order to accelerate the process.

After monitoring the results, EMA has to issue a scientific opinion that the commission uses to discuss with member states and give the official green light to the authorisation.

This final step by the commission, which can take up to 67 days, will be reduced to three days to ensure a quick distribution.

For the Pfizer/BioNTech vaccine, EMA expects to have a scientific opinion no later than 29 December - meaning that distribution could start early January.

The "conditional marketing authorisation" that companies will receive, which is foreseen under public health emergencies, holds the company accountable for the safety of the product - even after the approval is granted.

Moreover, the companies are responsible for monitoring the safety vaccines, reporting suspected adverse reactions to EMA and keeping product information up to date, while conducting safety and effectiveness studies regularly.

Hacked

The commission, on behalf of member states, has sealed deals with Moderna, AstraZeneca, Sanofi-GSK, Janssen Pharmaceutica NV, BioNTech/Pfizer and CureVac for up to two billion vaccine doses.

The EU executive said that once a vaccine is authorised, EU countries will get access to purchase the vaccines at the same time, on a population-based pro-rata basis.

Member states can also donate the vaccines to lower and middle-income countries or to re-direct it to other neighbouring countries.

Meanwhile, the commission's taxation and customs department has been targeted by hackers who have launched a "global phishing campaign" to gain insights about the Covid-19 vaccine 'cold supply chain', tech giant IBM revealed on Thursday.

Understanding how to build a secure cold chain may be key for the storage and distribution of vaccines like the one of BioNTech/Pfizer, which needs to be stored at minus 70 degrees to avoid spoiling.

EU commission keeps vaccine price secret

The European Commission is about to sign a fourth contract for hundreds of millions of vaccine doses against Covid-19. The contracts include non-disclosure clauses, meaning things like price or even where they will be produced remains confidential.

EU seeks new deal for '90% effective' Covid-19 vaccine

After an experimental Covid-19 vaccine developed by the American giant Pfizer and its German partner BioNTech was found to be more than 90 percent effective, the EU announced that it will sign a contract for up to 300 million doses.

EU leaders to discuss vaccine roll-out this month

EU leaders regularly held video-conferences to coordinate the pandemic reaction last year, but countries and EU institutions recently began a blame-game over the sluggish roll-out of vaccines.

News in Brief

  1. Poland curtails media access to Belarus border
  2. Report: Germany's Scholz 'backs compulsory Covid jabs'
  3. Omicron 'present in Europe at least 10 days ago'
  4. German court finds ex-Islamic State member guilty of genocide
  5. Report: Shell is considering return to Libya
  6. Report: EU to reveal €300bn infrastructure plan
  7. Barbados becomes world's newest republic
  8. Far-right Zemmour will run for French presidency

Surge of infections triggers new restrictions, despite vaccination

The spike in Covid-19 infections is prompting some EU governments to introduce lockdown measures and restrictions for the unvaccinated. Meanwhile, travel operators are calling for coordination and a common approach for booster doses and valid certificates.

Central Europe struggles with new Covid-19 wave

A new wave of Covid-19 infections has been sweeping through central Europe, where the vaccination rate is generally below the EU average - partly due to low trust in institutions.

Stakeholders' Highlights

  1. Nordic Council of MinistersNew report reveals bad environmental habits
  2. Nordic Council of MinistersImproving the integration of young refugees
  3. Nordic Council of MinistersNATO Secretary General guest at the Session of the Nordic Council
  4. Nordic Council of MinistersCan you love whoever you want in care homes?
  5. Nordic Council of MinistersNineteen demands by Nordic young people to save biodiversity
  6. Nordic Council of MinistersSustainable public procurement is an effective way to achieve global goals

Latest News

  1. No obligation to defend Ukraine from Russia, Nato chief says
  2. EU agency: 'Omicron vaccine' approval to take 3-4 months
  3. Ombudsman launches probe into Commission tobacco lobbying
  4. Lead MEP wants 'mandatory relocation' in EU asylum law
  5. The EU's 'global gateway' - an answer to China, or a dead-end?
  6. Osman Kavala in a Turkish jail - taking injustice personally
  7. Frontex implicated 'to some extent' in violations, says officer
  8. Omicron shows need for pandemic global pact, WHO says

Join EUobserver

Support quality EU news

Join us